July 24, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJuly 24, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreJuly 09, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
The adoption of advanced filtration technologies to boost the product quality, purity, and safety, as well as the growing demand for diverse biologics, vaccines are fueling the global market growth. North America led the market due to the expansion of the pharmaceutical industry and the development of innovative filtration technologies....
April 21, 2026
Based on market forecasts, the originator drug sector will expand from USD 24.54 billion in 2024 to USD 50.05 billion by 2034, experiencing a CAGR of 7.44%.The originator market is growing due to rising research in drug development. North America’s dominance is due to the presence of a strong pharmaceutical industry....
April 21, 2026
Market insights predict, the nicotine oral spray industry is expected to grow from USD 140 million in 2024 to USD 301.28 million by 2034, driven by a CAGR of 7.94%. The nicotine oral spray market is expanding due to growing health awareness, as well as due to its convenience and portability. Europe led the market due to the growing innovations....
April 21, 2026
Projections indicate that, the global HPMC capsules market will increase from USD 0.5 billion in 2024 to USD 1.25 billion by 2034, experiencing a CAGR of 9.44% over the next 10 years.The market is growing due to rising demand for plant-based, gelatin-free alternatives. Increasing use in pharmaceuticals and nutraceuticals for moisture-sensitive an...
April 21, 2026
Projections indicate that, the global GMP grade cytokines market will increase from USD 2.54 billion in 2024 to USD 6.48 billion by 2034, experiencing a CAGR of 9.84% over the next 10 years. The rising prevalence of chronic disorders and the burgeoning biotechnology sector drive the global market. North America led the global market owing to the ...
April 21, 2026
Market insights predict the global antibiotic-coated surgical implant drug industry will increase from USD 1.17 billion in 2024 to USD 3.05 billion by 2034, achieving a CAGR of 10.05%. The increasing number of surgeries and the rising prevalence of hospital-associated infections drive the global market. The presence of a robust healthcare infrast...
April 21, 2026
Due to the increasing burden of diverse cancer cases and demand for advanced chemotherapy drugs and services, the global market is expanding. The presence of advanced healthcare infrastructure and the growing demand for customized cancer care are driving North America....
April 21, 2026
According to market projections, the global anticoagulation monitoring devices market, valued at USD 1.55 billion in 2024, is anticipated to reach USD 3.13 billion by 2034, growing at a CAGR of 7.24% over the next decade.Rising geriatric population across the globe, rising adoption of novel oral anticoagulants (NOACs), and growing prevalence of c...
April 21, 2026
According to market projections, the CDK4/6 inhibitors sector is expected to grow from USD 11.38 billion in 2024 to USD 46.96 billion by 2034, reflecting a CAGR of 15.34%. The rising prevalence of cancer and growing research and development activities drive the global market. The availability of a state-of-the-art R&D infrastructure and the p...
April 21, 2026
Market insights predict the global radionuclide drug conjugates (RDC) industry will increase from USD 3.24 billion in 2024 to USD 8.87 billion by 2034, achieving a CAGR of 10.54%. The global radionuclide drug conjugates (RDC) market is growing strongly due to the growing cases of genetic disorders. North America is dominating due to technological...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
